Review

Nature Reviews Immunology 2, 239-250 (April 2002) | doi:10.1038/nri776

Subject Category: Vaccines

Vaccines: New hope for an aids vaccine

Harriet L. Robinson1  About the author

Top

The twenty-first century has begun with considerable success for new AIDS vaccines in macaque models. A common feature of these vaccines is their ability to induce high-frequency CD8+ T-cell responses that control, rather than prevent, infection with HIV. The new vaccines, which include DNA vaccines and live viral vectors, are based on technologies that have been developed since the start of the AIDS epidemic. The ultimate promise of these vaccines will be realized only when efficacy trials in humans are conducted.

Author affiliations

  1. Vaccine Research Center and Yerkes Primate Research Center of Emory University, 954 Gatewood Drive, NE, Atlanta, Georgia 30329, USA
    Email: hrobins@rmy.emory.edu
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated

NEWS AND VIEWS
AIDS vaccines: One step forwards, one step back
Nature News and Views (17 Jan 2002)

RESEARCH
Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations
Nature Medicine Article (01 May 1999)
Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity
Nature Letters to Editor (17 Jan 2002)
AIDS models: Microbicides could learn from vaccines
Nature Medicine Letters to Editor (01 May 2002)
See all 6 matches for Research

Extra navigation

Subscribe

Subscribe to Nature Reviews Immunology

Search PubMed for

Open Innovation Challenges

naturejobs

Advertisement